Nymox Pharmaceutical announces private placement

Nymox Pharmaceutical Corp. {NASDAQ: NYMX} announces a Private Placements of US $400,000.

In addition warrants at a strike price of $2 were issued.

 News Release

HASBROUCK HEIGHTS, N.J., March 20, 2015 — Nymox Pharmaceutical Corporation (Nasdaq: NYMX) announced today a recent private placement of 883,058 shares, with total proceeds of US$400,000.

In additional 441,529 warrants exercisable at $2.00 were included in the private placement.

For more information please contact info@nymox.com or 800-936-9669.

This press release contains certain “forward-looking statements” as defined in the United States Private Securities Litigation Reform Act of 1995 that involve a number of risks and uncertainties. There can be no assurance that such statements will prove to be accurate and the actual results and future events could differ materially from management’s current expectations. Development of drug products involves substantial risks and actual results may differ materially from expectations. Factors that could cause actual results or events to differ materially from those projected in forward-looking statements are detailed from time to time in Nymox’s filings with the United States Securities and Exchange Commission and other regulatory authorities.

CONTACT: Paul Averback
         Nymox Pharmaceutical Corporation